Pregnancy outcome after gestational exposure to mebendazole: A prospective controlled cohort study

American Journal of Obstetrics and Gynecology

Volumn 188, Issue 1, 2003, Pages 282-285

  Diav Citrin, Orna ^b   Shechtman, Svetlana ^b   Arnon, Judy ^b   Lubart, Israela ^b   Ornoy, Asher ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NONE

Author keywords

Congenital anomalies; Mebendazole; Pregnancy

Indexed keywords

ANTHELMINTIC AGENT; BECLOMETASONE; BENZIMIDAZOLE DERIVATIVE; CLOTRIMAZOLE; DEXAMETHASONE; DEXPANTHENOL; MEBENDAZOLE; NEOMYCIN;

ADULT; ARTICLE; BIRTH WEIGHT; CONGENITAL MALFORMATION; CONTROLLED STUDY; GESTATIONAL AGE; GREAT VESSELS TRANSPOSITION; HELMINTHIASIS; HUMAN; HYDRONEPHROSIS; INFANT; KIDNEY AGENESIS; KIDNEY MALFORMATION; LUNG HYPOPLASIA; MAJOR CLINICAL STUDY; PARASITISM; PREGNANCY; PRIORITY JOURNAL; TERATOGENICITY; TREATMENT OUTCOME;

EID: 0037248752     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.79     Document Type: Article

References (19)

1. American Academy of Pediatrics. Pinworm infestation (Enterobius vermicularis). In: Peter G, editor. 1997 Red book: report of the committee on infectious diseases. 24th ed. Elk Grove Village (IL): American Academy of Pediatrics; 1997. p. 407-8.
2. D'Alauro F, Lee RV, Pao-In K, Khairallah M. Intestinal parasites and pregnancy. Obstet Gynecol 1985;66:639-43.
3. Ellis CJ. Antiparasitic agents in pregnancy. Clin Obstet Gynecol 1986;13:269-75.
4. Leach FN. Management of threadworm infestation during pregnancy. Arch Dis Child 1990;65:399-400.
5. Product information. Vermox. Titusville (NJ): Janssen Pharmaceutical, Inc; 1993.
6. Shepard TH. Catalog of teratogenic agents. 8th ed. Baltimore (MD): Johns Hopkins University Press; 1985. p. 261.
7. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 5th ed Baltimore (MD): Williams & Wilkins; 1998. p. 658-9.
8. de Silva NR, Sirisena JLGJ, Gunasekera DPS, Ismail MM, de Silva HJ. Effect of mebendazole therapy during pregnancy on birth outcome. Lancet 1999;353:1145-9.
9. Witassek F, Burkhardt B, Eckert J, Bircher J. Chemotherapy of alveolar echinococcosis: comparison of plasma mebendazole concentrations in animals and man. Eur J Clin Pharmacol 1981;20:427-33.
10. Tracy JW, Webster LT Jr. Drugs used in the chemotherapy of helminthiasis. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill; 1996. p. 1009-26.
11. Delatour P, Lorgue G, Lapras M, Deschanel JP. Embryotoxic properties (rat) and residues (sheep, cattle) of three anthelmintic derivatives of benzimidazole [in French]. Bull Soc Sci Vet Med Comp Lyon 1974;76:147-54.
12. Delatour P, Richard Y. Embryotoxic and antimitotic properties of some benzimidazole related compounds [in French]. Therapie 1976;31:505-15.
13. Beard TC, Rickard MD, Goodman HT. Medical treatment for hydatids. Med J Aust 1978;1:633-5.
14. Zutel AJ, Barreiro CZ, de Negrotti TC, de Tello AMB, del Valle Torrado M. Drug related prenatal syndromes [in Portugese]. Rev Hosp Ninos B Aires 1977;19:281-9.
15. Blondheim DS, Klein R, Ben Dror G, Schick G. Trichinosis in southern Lebanon. Isr J Med Sci 1984;20:141-4.
16. Draghici O, Vasadi T, Draghici G, Codrea A, Mihuta A, Dragan S, et al. Comments with reference to trichinellosis focus. Rev Ig (Bacteriol) 1976;21:99-104.
17. Diav-Citrin O, Shechtman S, Gotteiner T, Arnon J, Ornoy A. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study. Teratology 2001;63:186-192.
18. Holmes LB. Need for inclusion and exclusion criteria for the structural abnormalities recorded in children born from exposed pregnancies [editorial]. Teratology 1999;59:1-2.
19. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Litteleton (MA): Publishing Sciences Group; 1977.